Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

ADMA BIOLOGICS, INC. (ADMA) · INSIDER

Data sources

SEC Form 433m ago

House PTR33m ago

SEC 13F33m ago

Robinhood Chain33m ago

Public company

ADMA BIOLOGICS, INC.

ADMACIK 0001368514

EDGAR filings Open in network

Price$12.73

1 year-17.2%

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections with evidence3

ADMA · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Insider ofevidence
Grossman Adam S.Director, Officer · Form 144 · Nov 4, 2026
← Lobbied forevidence
AMERICAN DEFENSE INTERNATIONALLDA Q1 2026 first quarter · Health issues · Aug 26, 2026

Lobbying

$10K reported · de-duplicated

2026 Q2 $10K via firms2026 Q1 $0 via firms

AMERICAN DEFENSE INTERNATIONAL$10K2026 Q2 · posted Aug 26, 2026 · Health issues
AMERICAN DEFENSE INTERNATIONAL—2026 Q1 · posted Aug 26, 2026 · Health issues

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.

Planned sales and 5% stakes

Form 144, 13D and 13G

Grossman Adam S.Director, Officer · sale around Nov 5, 2026 · 189.0K shares · 10b5-1 plan$1.98MForm 144 · filed Nov 5, 2026